Search results for:
acyclovir
acyclovir
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Zovirax |
CAPSULE, ORAL |
200 mg |
|
|
|
|
| Zovirax |
SOLUTION, INTRAVENOUS |
50 mg/mL |
|
|
|
|
| Zovirax |
SUSPENSION, ORAL |
200 mg/5 mL |
|
|
|
|
| Sitavig |
TABLET, BUCCAL |
50 mg |
|
|
|
|
| Zovirax |
TABLET, ORAL |
400 mg, 800 mg |
|
|
|
|
Last updated: May. 13, 2026
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
acyclovir (Sitavig)
valACYclovir (Valtrex)
Sitavig is classified as non-formulary, not stocked.
Automatic renal adjustment per guidelines. See Antimicrobial Dosing Guideline and Renal Adjustment Policy (Adult) for more information. CrCl calculation policy available here.
Acyclovir Weight-Based Dosing Guideline (LINKED)
Category A Vesicant: See Management of Extravasation of Irritant and Vesicant Drugs (Non-Chemotherapy) - ADULTS and Management of Extravasation of Irritant and Vesicant Drugs (Non-Chemotherapy) PEDIATRIC
Powerplans: HOSP Vesicant Extravasation Management Orders and PEDS Vesicant Extravasation Management Orders
Drug Shortage Management Strategy: NOT IN EFFECT
IV Acyclovir Shortage Management Dec 2025
Reviewed: August 26, 2014 (Sitavig), October 22, 2019, November 2019 (Shortage Management Strategy)